Previous Close | 4.0800 |
Open | 4.0600 |
Bid | 4.1400 x 200 |
Ask | 4.2400 x 200 |
Day's Range | 4.0200 - 4.2000 |
52 Week Range | 3.1700 - 5.7500 |
Volume | |
Avg. Volume | 2,933,307 |
Market Cap | 1.132B |
Beta (5Y Monthly) | 1.32 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.08 |
Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 millionConvertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common stock and approximately $8.9 millionTotal debt reduced since December 31, 2023 is approximately $41.8 million DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled thera
Key Insights Given the large stake in the stock by institutions, MannKind's stock price might be vulnerable to their...
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.